MLL2, also known as KMT2D (Lysine Methyltransferase 2D), of which mutation is a driver in numerous different cancer types resulting in transcription stress and genome instability (36), and a recent study demonstrated that MLL2 could sustain prostate carcinogenesis and metastasis (37). Here, KMT2D is linked to cancer.